Resectable Pancreatic Adenocarcinoma Clinical Trials

17 clinical trials for Resectable Pancreatic Adenocarcinoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation — RECRUITING · PHASE2
• Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer — RECRUITING · PHASE2
• Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) — RECRUITING · PHASE1
• A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer — RECRUITING
• Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial — RECRUITING · PHASE2
• Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 — RECRUITING · NA
• Identify microRNAs in Cachexia in Pancreatic Carcinoma — TERMINATED
• Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer — OTHER · PHASE1
• Intraoperative Radiation Therapy for Resectable Pancreatic Cancer — COMPLETED · NA
• Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis — OTHER
• A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma — OTHER · PHASE2
• Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma — OTHER · NA
• Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma — COMPLETED · PHASE1
• Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer — OTHER · PHASE2

Refine this search